Crestline Management’s Zoetis ZTS Stock Holding History

Crestline Management’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,914	Closed	-$475K	–	681
2024 Q4	$475K	Buy	+2,914	New	+$521K	0.02%	550

Other funds holding ZTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Crestline Management's ZTS Position: Q1 2025 in Review

Crestline Management sold out of Zoetis (ZTS) in Q1 2025, closing a stake of 2,914 shares — an estimated $475K sold.

Crestline Management first reported a position in ZTS in Q4 2024 and held it in 1 quarter. The position peaked at $475K in Q4 2024. 1,886 funds tracked by Wall St. Rank hold ZTS as of Q1 2025.

Crestline Management reported no remaining Zoetis position as of Q1 2025 after selling out during the quarter.
Crestline Management sold 2,914 Zoetis shares in Q1 2025, an estimated $475K.
Crestline Management first reported a position in Zoetis in Q4 2024 and held it in 1 quarter.
Crestline Management's Zoetis position peaked at $475K in Q4 2024.
1,886 funds tracked by Wall St. Rank held Zoetis as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.